Clinical Trial Update: Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase II trial of FOLFOX6 with Bevacizumab and Cetuximab in colorectal cancer has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Cetuximab (cetuximab)
• FOLFOX6

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Rectum, Mucinous Adenocarcinoma of the Colon | Phase 2 | Status: COMPLETED | Results posted: 2015-07-27